Editor: How about overseas expansion?
Kono: In the first place, there is no framework or restriction of "remote diagnosis" in developing countries. In addition, our products are more competitively priced than other companies' products that are widely used overseas. Furthermore, in developing countries, the number of medical specialists is small, and doctors are inevitably located in remote areas, so the need for technology that can measure and transmit data like "iCTG" is high. The widespread use of "iCTG" will also help improve the level of midwives and nurses in hospitals with pregnant women. This is because they will be able to communicate with specialists through data. We believe that this will improve the quality of medical care and prevent unfortunate accidents.
After the interview...
First of all, I was very impressed by the high level of ambition of the people involved in the product development. I believe that the spread of this kind of technology is essential to address the current situation in rural areas where there is a shortage of doctors. I hope that remote diagnosis in obstetrics and gynecology will be approved in Japan as soon as possible. I hope that this technology will be approved in Japan as soon as possible, and I also hope that it will contribute to the international community.
Melody International Ltd Official website.
https://melody.international/
